These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 13446417)

  • 1. The combined use of isoniazid and nupasal-213 in pulmonary tuberculosis; a study of the toxic effects and the development of cross-resistance between isoniazid and nupasal-213 in the treatment of pulmonary tuberculosis.
    CUTHBERT J; BRUCE LG
    Br J Tuberc Dis Chest; 1957 Jul; 51(3):265-70. PubMed ID: 13446417
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical observations on th possibility of use in the treatment o pulmonary tuberculosis of a new derivative of isoniazid: 2-carboxybenzaldehydeisonicotinoylhydrazone].
    SBRAGIA S
    Lotta Tuberc; 1960; 30():255-69. PubMed ID: 14442170
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies of the PAS salt of isoniazid in the treatment of tuberculosis.
    EVANDER LC; ROSE NR; BEUTNER EH; TASHIRO K; DOYLE W
    Am Rev Tuberc; 1958 Oct; 78(4):637-43. PubMed ID: 13583426
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chemotherapy of pulmonary tuberculosis with nicoteben-compositum].
    KROBER KH
    Med Klin; 1958 Feb; 53(8):302-4. PubMed ID: 13540857
    [No Abstract]   [Full Text] [Related]  

  • 5. [The use of sulfoniazide in forms of pulmonary tuberculosis in childhood].
    SILANOS G
    Clin Pediatr (Bologna); 1959 Oct; 41():826-46. PubMed ID: 14446638
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapy of tuberculosis. III. Verazide in the treatment of pulmonary tuberculosis.
    RUBBO SD; ROUCH LC; EGAN JB; WADDINGTON AL; TELLESSON WG
    Am Rev Tuberc; 1958 Aug; 78(2):251-8. PubMed ID: 13559656
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyanacethydrazide therapy in pulmonary tuberculosis.
    KIRSHNER JJ
    Dis Chest; 1957 Oct; 32(4):413-20. PubMed ID: 13473655
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of pulmonary tuberculosis with high dosage of isoniazid derivative (Na-methansulfonate-IHMS) combined with PAS. The results of primary treatment of infiltrative caseous lesions].
    OHSATO T
    Kekkaku; 1960 Oct; 35():668-74. PubMed ID: 13730529
    [No Abstract]   [Full Text] [Related]  

  • 9. Ethionamide in re-treatment of eleven patients with pulmonary tuberculosis.
    SLAVIN P
    Am Rev Respir Dis; 1962 May; 85():745-9. PubMed ID: 13913830
    [No Abstract]   [Full Text] [Related]  

  • 10. Further observations on the antibacterial activity to Mycobacterium tuberculosis of a derivative of isoniazid, omicron-hydroxybenzal isonicotinylhydrazone (nupasal-213).
    BAVIN EM; JAMES B; KAY E; LAZARE R; SEYMOUR DE
    J Pharm Pharmacol; 1955 Dec; 7(12):1032-8. PubMed ID: 13278849
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of therapy of pulmonary tuberculosis with a combination of Neoiscotin and Erycon].
    HAGIHARA K; ITO N; TAKEUCHI K; KAJIMA H; DEGUCHI T
    Iryo; 1961 Aug; 15():661-6. PubMed ID: 13903641
    [No Abstract]   [Full Text] [Related]  

  • 12. [The use of fenazid in patients with pulmonary tuberculosis with poor isoniazid tolerance].
    Borisova MI; Stakhanov VA; Sharkova TI; Ivashchenko NA
    Probl Tuberk Bolezn Legk; 2003; (7):34-7. PubMed ID: 12939876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The anti-tuberculosis activity of sulfoniazide].
    BARIETY M; CHOUBRAC P
    Presse Med (1893); 1957 Jan; 65(2):21-2. PubMed ID: 13420000
    [No Abstract]   [Full Text] [Related]  

  • 14. [ON PRIMARY DRUG RESISTANCE OF MYCOBACTERIUM TUBERCULOSIS IN PATIENTS WITH PULMONARY TUBERCULOSIS].
    PUCHKOV VV; CHERNITSKII GI
    Probl Tuberk; 1964; 42():14-7. PubMed ID: 14241333
    [No Abstract]   [Full Text] [Related]  

  • 15. [Isonicotinylhydrazone of furyl-2-methyl ketone].
    GENAZZANI E; PAOLETTI A
    Minerva Med; 1958 Dec; 49(98 Suppl):4591-7. PubMed ID: 13622370
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical picture and therapy of patients with a combined course of infectious hepatitis and pulmonary tuberculosis].
    Titov MB
    Vrach Delo; 1968 Aug; 8():117-21. PubMed ID: 5754334
    [No Abstract]   [Full Text] [Related]  

  • 17. A CONTROLLED CLINICAL TRIAL OF ISONIAZID AND HETEROCYCLIC THIOSEMICARBAZONE COMPARED WITH ISONIAZID AND PAS IN PULMONARY TUBERCULOSIS.
    JANCIK E; TOUSEK J; MAKOVA M; ZELENKA M
    Tubercle; 1963 Dec; 44():431-42. PubMed ID: 14101323
    [No Abstract]   [Full Text] [Related]  

  • 18. [THE ROLE OF ACETYLATION IN THE EFFECTIVENESS OF TREATMENT WITH COMBINED ISONIAZID AND PARA-AMINOSALICYLIC ACID, AND ISONIAZID WITH PARA-AMINOBENZOIC ACID, IN PULMONARY TUBERCULOSIS].
    VITOLO A
    Bull Sci Med (Bologna); 1963; 135():396-402. PubMed ID: 14112984
    [No Abstract]   [Full Text] [Related]  

  • 19. [Phythyvazid-resistance of myobacterium tuberculosis and its clinical importance].
    Belogurova VP; Dargevich VK
    Sov Med; 1966 Mar; 29(3):66-72. PubMed ID: 4967965
    [No Abstract]   [Full Text] [Related]  

  • 20. [Contribution to the knowledge of the clinical antitubercular activity of sulfoniazid].
    RAVAZZONI C; SADOWSKI LF; SCARPONI F
    Lotta Tuberc; 1959; 29():943-54. PubMed ID: 14436538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.